THE APEX TIMES
A recent market note pointed to Berkshire Hathaway’s gains in 2026 versus a largely flat Nasdaq 100 and raised the question of whether investors should reduce tech exposure in favor of the conglomerate. The post, however, did not offer new, company-specific disclosures to substantiate a definitive shift.
Berkshire Hathaway’s stock has drawn fresh attention from retail and market commentators after a widely shared investing column highlighted the company’s performance in 2026 compared with the Nasdaq 100. The piece, published by Yahoo Finance via a republishing site, framed the gap as an argument for “old-economy” diversification when investors grow weary of technology volatility.
According to the article’s headline and description, Berkshire Hathaway is up about 14% in 2026 while the Nasdaq 100 has “gone nowhere,” a reference to a relatively subdued index performance over the same period. The post also pointed to a “brutal November sell-off” in technology, using that drawdown as context for why some investors are reconsidering portfolio positions.
The column suggested that Warren Buffett’s conglomerate could function as a “lifeboat” during tech weakness, but it did not, in the information provided here, cite new Berkshire filings, balance-sheet changes, or specific transactions that would explain the move in the shares. As a result, the underlying driver of Berkshire’s relative strength is not independently established in the material available for this review.
The article further alluded to Berkshire’s own recent moves and to “one big historical weakness,” implying that investors should weigh both momentum and risks that have appeared before. Still, the available excerpt does not specify what those moves were, what historical weakness the writer meant, or when the cited actions occurred, leaving key factual details unverified for editorial purposes.
For Berkshire Hathaway, the core investment proposition is longstanding: it is a diversified holding company with operating businesses and significant equity and fixed-income exposure. That structure can help smooth results across economic cycles, but whether that protection applies to any given quarter depends on which underlying assets are actually performing and how quickly markets reprice them.
Sector-wise, the renewed comparison between Berkshire and the Nasdaq is a familiar pattern in periods when leadership in equities narrows. When technology sells off while broader indexes flatten, investors tend to ask whether the concentration risk in growth stocks is temporarily or structurally elevated, and whether diversified conglomerates offer better risk-adjusted returns.
A limitation of relying on the reposted commentary is that it offers an opinionated framing rather than new disclosures. In the information available for this story, Berkshire did not publish any accompanying statement, and no primary document such as an earnings release, quarterly filing, or investor presentation is provided to corroborate the article’s implied explanation for the stock’s outperformance.
Going forward, investors looking for more than a headline comparison would need to anchor any “rotate away from tech” thesis in Berkshire’s disclosed fundamentals. The next key step would be reviewing Berkshire’s latest official communications and filings to see what, if anything, changed in its operating results, capital allocation, or investment portfolio during 2026.
Absent those specifics, the most defensible conclusion from the available material is narrow: Berkshire Hathaway has been gaining in 2026 while the Nasdaq 100 has lagged, and commentators are using that divergence to question whether investors should re-think tech exposure. For readers, the actionable uncertainty is what portions of Berkshire’s performance are attributable to market beta versus company-specific choices.
A market-focused note argues the company’s cash-return profile could matter as Wall Street debates whether 2027 can resemble 2022. The company, however, did not provide new disclosure in the cited post.
A market report said the U.S. Securities and Exchange Commission has opened an investigation involving Nvidia as the chipmaker absorbs fallout from a sharp selloff. Investors now have to parse what the agency is looking at and how much the matter could weigh on disclosures and governance.
A reported Phase 3 win for Moderna’s personalized melanoma therapy, used alongside Merck’s Keytruda, is prompting fresh optimism that the mRNA platform can expand beyond infectious disease. Still, key details such as magnitude of benefit and full trial disclosure remain to be validated.
Marques Brownlee said he has placed an order for Tesla’s Cybercab following a 2024 challenge, and Tesla CEO Elon Musk replied “fair enough,” saying he would accept delivery.
A new market read on Booz Allen Hamilton Holding points to a sizable gap between the company’s valuation and the cash flow the business can generate, sharpening questions for investors about how durable profits and cash generation are in the defense IT services market.
The company is pursuing Australian National Immunisation Program listings for its mRNA influenza vaccines after securing a March 2027 agenda spot with the PBAC, a key committee that advises public reimbursement.
A newly announced partnership between Microsoft and Danaher aims to pair AI-assisted capabilities with cloud-based scientific instruments and lab software, including early tools that are already moving toward commercial use.
A new market round-up from Yahoo Finance highlights how lingering discussion among Fed officials about whether interest rates need to rise again can reshape expectations for large, consumer-facing companies like PepsiCo.
The initiative, launched within Aetna, is designed to link a large share of expectant members and their newborns to coordinated maternal and infant care. CVS Health has not, in the reporting, disclosed staffing, clinical protocols, or outcome targets tied to the program.
A fresh round of holiday changes at Target centers on shopping hours and promotions, a shift the company is indicating as part of how it intends to drive demand into the end of the year.
Comments
Community guidelines. Comments may be removed for violations.
Loading comments...